GR 103545

Known as: GR-103545, GR103545 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2011
01219902011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
INTRODUCTION GR103545 is a potent and selective kappa-opioid receptor agonist. Previous studies in non-human primates… (More)
  • figure 1
  • table 1
Is this relevant?
2007
2007
LY255582 is a pan opioid selective receptor antagonist that has been shown to have high affinity for mu, delta, and kappa… (More)
Is this relevant?
2005
2005
UNLABELLED Brain kappa-opioid receptors (ORs) may be involved in several pathologic conditions, such as addiction, psychosis, and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2005
2005
Brain -opioid receptors (ORs) may be involved in several pathologic conditions, such as addiction, psychosis, and seizures. ( )-4… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2002
2002
The R and S enantiomers of [(11)C]GR89696, [(11)C]-methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)methyl]-1… (More)
Is this relevant?
1993
1993
1. The evidence for kappa-receptor heterogeneity is equivocal. We have now investigated this question by comparing the effects of… (More)
Is this relevant?
1993
1993
1. Effects of the alpha 2-adrenoceptor agonists, UK14304 and clonidine, the 5-HT1 receptor agonist, sumatriptan and the kappa… (More)
Is this relevant?
1992
1992
1. The pharmacological profile of GR94839, a kappa-opioid agonist with limited access to the central nervous system, has been… (More)
Is this relevant?
1990
1990
1. This paper describes the opioid receptor pharmacology and in vivo activity of several novel benzene-acetamidopiperidine and… (More)
Is this relevant?